Vivek Subbiah: We Don’t Just Write What We Know, We Write to Discover What We Could Know
Vivek Subbiah, Chief of Early-Phase Drug Development at Sarah Cannon Research Institute, shared a post on X published in Nature Reviews Bioengineering.
“Writing is thinking.
A powerful editorial in Nature Reviews Bioengineering (Vol. 3, p. 431, 2025) reminds us of something timeless: in science, writing is far more than reporting results. It’s a way of sharpening thought.
Even in an age shaped by large-language models, human-generated scientific writing remains essential. The act of writing demands structure, intention, and clarity turning wandering ideas into insight and innovation.
We don’t just write what we know. We write to discover what we could know.”
Title: Writing is thinking
Read The Full Article at Nature Reviews Bioengineering.
More posts featuring Vivek Subbiah on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023